HEALEY ALS Platform Trial so farAnticipated topline efficacy and safety results for NUZ-001 now expected in late Q2 CY2027Completion of recruitment materially de-risks execution of Neurizon's lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results